These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9817630)

  • 21. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
    Koesters M; Becker T; Weinmann S
    Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case report. Venlafaxine--new treatment of painful peripheral diabetic neuropathy].
    Lithner F
    Lakartidningen; 2000 Sep; 97(39):4311. PubMed ID: 11076473
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial.
    Sonne C; Carlsson J; Elklit A; Mortensen EL; Ekstrøm M
    Trials; 2013 May; 14():137. PubMed ID: 23663588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine and SSRI remission data revisited.
    Kavirajan H
    Br J Psychiatry; 2004 May; 184():452-3. PubMed ID: 15123513
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of venlafaxine.
    Ballenger JC
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
    Stein DJ; Pedersen R; Rothbaum BO; Baldwin DS; Ahmed S; Musgnung J; Davidson J
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):23-31. PubMed ID: 18544181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM
    Clin Ther; 2002 Jul; 24(7):1194-200. PubMed ID: 12182262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venlafaxine versus sertraline for major depressive disorder.
    Wise TN; Sheridan MJ
    J Clin Psychiatry; 2000 Nov; 61(11):873-4. PubMed ID: 11105744
    [No Abstract]   [Full Text] [Related]  

  • 30. The review by Weinmann and colleagues.
    Freemantle N
    Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
    Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
    Thase ME; Entsuah AR; Rudolph RL
    Br J Psychiatry; 2001 Mar; 178():234-41. PubMed ID: 11230034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joy returns last: anhedonia and treatment resistance in depressed adolescents.
    Rubin DH
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):353-5. PubMed ID: 22449641
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML; Garfield LD; Teitelbaum S; Civitelli R; Mulsant BH; Reynolds CF; Dixon D; Doré P; Lenze EJ
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
    Möller HJ; Volz HP
    Drugs; 1996 Nov; 52(5):625-38. PubMed ID: 9118813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine: Successful treatment in impulsive disorders.
    Camardese G; Picello A; Bria P
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
    [No Abstract]   [Full Text] [Related]  

  • 39. Saving lives: can we predict and prevent adolescent suicide?
    Weder N
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):339-40. PubMed ID: 22449635
    [No Abstract]   [Full Text] [Related]  

  • 40. Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
    Smajkić A; Weine S; Durić-Bijedić Z; Boskailo E; Lewis J; Pavković I
    Med Arh; 2001; 55(1 Suppl 1):35-8. PubMed ID: 11795192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.